- Record: found
- Abstract: found
- Article: not found
Long-term outcomes of prostaglandin analog versus timolol maleate in ocular hypertensive or primary open-angle glaucoma patients in Europe.
Gábor Holló
1 ,
Ulrich Thelen ,
Miguel A Teus ,
Luciano Quaranta ,
Sylvia Ferkova ,
Nikola Babić ,
Marta Misiuk-Hojlo ,
Dimitrios G Mikropoulos ,
Bartlomiej J Kaluzny ,
Vassilios Kozobolis ,
Ingrida Januleviciene ,
Péter Kóthy ,
Cristina Camara ,
Andrea Russo ,
Patrycja Krzyzanowska-Berkowska ,
Iwona Cieślińska ,
Jeanette A Stewart ,
Michael S Kristoffersen ,
Lindsay A Nelson ,
William C Stewart
Oct 2011
Read this article at
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
To determine the direct costs of therapy over 5 years of a European monotherapy cohort begun on a prostaglandin (PTG) versus timolol in patients with primary open-angle glaucoma or ocular hypertension.